Spots Global Cancer Trial Database for induction chemotherapy
Every month we try and update this database with for induction chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | NCT00868491 | Head and Neck C... | docetaxel, cisp... radiotherapy cetuximab, cisp... | 18 Years - | Institute of Oncology Ljubljana | |
| Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
| Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin | NCT02562599 | Nasopharyngeal ... | raltitrexed-cis... Intensity-modul... | 18 Years - 70 Years | Hubei Cancer Hospital | |
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | NCT04437329 | Nasopharyngeal ... | Docetaxel, neda... Docetaxel, cisp... Nedaplatin Cisplatin Intensity modul... | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | NCT04776447 | Lung Diseases Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Respiratory Tra... Carcinoma Bronc... Thoracic Neopla... | Carboplatin Placlitaxel Atezolizumab | 18 Years - 75 Years | Fundación GECP | |
| Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma | NCT03984357 | Nasopharyngeal ... | PD-1 blocking a... Gemcitabine Cisplatin Intensity-modul... | 18 Years - 65 Years | Sun Yat-sen University | |
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | NCT04437329 | Nasopharyngeal ... | Docetaxel, neda... Docetaxel, cisp... Nedaplatin Cisplatin Intensity modul... | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma | NCT03984357 | Nasopharyngeal ... | PD-1 blocking a... Gemcitabine Cisplatin Intensity-modul... | 18 Years - 65 Years | Sun Yat-sen University | |
| A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer | NCT01491737 | Breast Cancer | Pertuzumab Trastuzumab Aromatase Inhib... Induction Chemo... | 18 Years - | Hoffmann-La Roche | |
| Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer | NCT00460551 | Non Small Cell ... | Zalutumumab Induction chemo... Radiotherapy | 18 Years - | Genmab | |
| Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors | NCT02519712 | Acute Myeloid L... | Induction Chemo... G-PBSC Infusion | 60 Years - | Memorial Sloan Kettering Cancer Center | |
| A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy | NCT05622474 | Nasopharyngeal ... | Induction chemo... Concurrent chem... IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy | NCT04384627 | Nasopharyngeal ... Induction Chemo... Radiotherapy | Delineating the... | 18 Years - 70 Years | Sun Yat-sen University | |
| Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT01245959 | Nasopharyngeal ... | Docetaxel, cisp... Concurrent chem... | 18 Years - 59 Years | Sun Yat-sen University | |
| Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases | NCT05012254 | Non Small Cell ... Brain Metastase... Lung Cancer | Ipilimumab Nivolumab Carboplatin Cisplatin Paclitaxel Pemetrexed | 18 Years - | Fundación GECP | |
| Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma | NCT02360501 | Nasopharyngeal ... | Docetaxel Cisplatin Capecitabine | 18 Years - 75 Years | Sun Yat-sen University | |
| Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer | NCT06039631 | Larynx Cancer Hypopharyngeal ... | Surgery Radiation Toripalimab | 18 Years - 75 Years | Fudan University | |
| Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | NCT03367884 | Hypopharyngeal ... | Neck dissection... Definitive radi... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) | NCT00431613 | Non Small Cell ... | Docetaxel Gemcitabine Carboplatin Chemoradiothera... Docetaxel | 19 Years - 75 Years | Hellenic Oncology Research Group | |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT | NCT05628922 | Nasopharyngeal ... | Toripalimab Induction chemo... | 18 Years - 70 Years | Fudan University | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer | NCT04296747 | Hypopharyngeal ... | induction chemo... surgery chemoradiothera... | 18 Years - | Peking Union Medical College Hospital | |
| Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed For Children With Acute Lymphocytic Leukemia | NCT01600781 | Acute Lymphocyt... | NutriniDrink/Fo... | 2 Years - 12 Years | Children's Cancer Hospital Egypt 57357 | |
| Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer | NCT04539600 | Hypopharyngeal ... Immunotherapy Induction Chemo... | Camrelizumab | 18 Years - 75 Years | Sun Yat-sen University | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence | NCT05054959 | Locally Advance... | consolidation c... induction chemo... | 18 Years - | Institute of Oncology Ljubljana | |
| Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer | NCT02403531 | Neoplasms | Docetaxel Cisplatin Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | NCT02786641 | Nasopharyngeal ... | Docetaxel Cisplatin 1 Xeloda IMRT Cisplatin 2 | 18 Years - 65 Years | Sun Yat-sen University | |
| Clarithromycin in Multiple Myeloma Induction Therapy | NCT02573935 | Multiple Myelom... | Clarithromycin Placebo VCD induction t... | 18 Years - | Aalborg University Hospital | |
| SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | NCT00002735 | Head and Neck C... | Induction chemo... cisplatin fluorouracil low-LET cobalt-... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma | NCT02066220 | Brain Tumors | Radiotherapy wi... Reduced-intensi... Radiotherapy wi... Maintenance che... WNT-HR < 16 yea... WNT-HR >= 16 ye... Induction Chemo... SHH-TP53 M0 SHH-TP53 M+ (ge... SHH-TP53 (somat... Vinblastin Main... | 3 Years - 21 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer | NCT06093438 | Cervical Cancer Induction Chemo... Immunotherapy | Toripalimab | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) | NCT05520619 | Esophageal Squa... Locally Advance... | Paclitaxel, Cis... tislelizumab Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma | NCT04143984 | Nasopharyngeal ... | Induction chemo... Carbon-ion radi... Camrelizumab | 18 Years - 70 Years | Shanghai Proton and Heavy Ion Center | |
| Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain | NCT05304468 | Nasopharyngeal ... | IMRT induction chemo... cisplatin concu... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60 | NCT04083911 | Acute Myeloid L... Induction Chemo... | Decitabine, Hom... | 60 Years - 79 Years | The First Affiliated Hospital of Soochow University | |
| Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma | NCT05420597 | Laryngeal Cance... Hypopharyngeal ... | Toripalimab | 18 Years - 75 Years | Fudan University | |
| Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma | NCT02360501 | Nasopharyngeal ... | Docetaxel Cisplatin Capecitabine | 18 Years - 75 Years | Sun Yat-sen University | |
| InductionChemo-Radio-Antibody-Treatment | NCT01181401 | Squamous Cell C... Squamous Cell C... | TPF induction c... TPF experimenta... Standard Radioc... | 18 Years - | Charite University, Berlin, Germany | |
| PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma | NCT03791905 | Neoplasm, Esoph... Squamous Cell C... | Paclitaxel Cisplatin Oxaliplatin 5-FU Leucovorin Intensity-modul... PET | 18 Years - 70 Years | Sun Yat-sen University | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC | NCT06156891 | Oropharyngeal C... | Toxicities redu... Conventional tr... | 18 Years - 70 Years | Fudan University | |
| Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT03020329 | Nasopharyngeal ... Children | Paclitaxel lipo... Cisplatin 5-fu Radical radioth... | - 18 Years | Sun Yat-sen University | |
| Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer | NCT02945631 | Locally Advance... | PTV56 PTV50.4 | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies | NCT04710212 | Hematologic Mal... Leukemia, Acute Neutropenia Bloodstream Inf... | No intervention... | 18 Years - | Duke University | |
| Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | NCT01440270 | Locally Advance... Oral Cancer Oropharyngeal C... | Neo-adjuvant Er... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) | NCT01326559 | Nasopharyngeal ... | Docetaxel, Cisp... | 18 Years - 70 Years | Hong Kong Nasopharyngeal Cancer Study Group Limited | |
| Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients | NCT02604472 | Malignant Neopl... | CCRT IC+CCRT | - | Sun Yat-sen University | |
| InductionChemo-Radio-Antibody-Treatment | NCT01181401 | Squamous Cell C... Squamous Cell C... | TPF induction c... TPF experimenta... Standard Radioc... | 18 Years - | Charite University, Berlin, Germany | |
| Induction Chemotherapy for Locally Recurrent Rectal Cancer | NCT04389086 | Recurrent Recta... | Combination dru... Chemoradiothera... Surgery locally... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
| Laryngeal Preservation in Pyriform Sinus Carcinoma | NCT00770393 | Squamous Cell C... | induction chemo... Conventionnal c... | 18 Years - 70 Years | Centre Hospitalier Universitaire de Saint Etienne | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia | NCT01297543 | Acute Myeloid L... Acute Lymphobla... Chronic Myeloid... Myelodysplasia | human myeloid p... G-CSF | 18 Years - | Cellerant Therapeutics | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT05527782 | Locally Advance... | modified TPF Quality of life... | 18 Years - | Hospital Universitario Doctor Peset | |
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) | NCT06255210 | Olfactory Neuro... | Gemcitabine+Cis... | 18 Years - | Eye & ENT Hospital of Fudan University | |
| Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | NCT02454647 | Gastric Cancer Adenocarcinoma Effects of Chem... Surgery Gastrointestina... | Induction chemo... Radiotherapy wi... Salvage surgery | 18 Years - 80 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Nedaplatin in Treatment for Nasopharyngeal Carcinoma | NCT04834206 | Nasopharyngeal ... | Docetaxel, neda... IMRT Nedaplatin | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer | NCT06093438 | Cervical Cancer Induction Chemo... Immunotherapy | Toripalimab | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) | NCT06255210 | Olfactory Neuro... | Gemcitabine+Cis... | 18 Years - | Eye & ENT Hospital of Fudan University | |
| Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma | NCT05979961 | Nasopharyngeal ... | IMRT and concur... gemcitabine and... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | NCT04087967 | Acute Myeloid L... Induction Chemo... | Decitabine plus... Idarubicine plu... | 18 Years - 59 Years | The First Affiliated Hospital of Soochow University | |
| TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | NCT01542931 | Stage III Oral ... Stage IVA Oral ... | TPF induction c... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma | NCT02360501 | Nasopharyngeal ... | Docetaxel Cisplatin Capecitabine | 18 Years - 75 Years | Sun Yat-sen University | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | NCT01440270 | Locally Advance... Oral Cancer Oropharyngeal C... | Neo-adjuvant Er... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | NCT03170115 | Rectal Cancer, ... Locally Advance... Chemoradiation | Aspirin Placebo Oral Ta... | 18 Years - 75 Years | Instituto Nacional de Cancer, Brazil | |
| The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | NCT02096380 | Nasopharyngeal ... | One cycle TPF i... Three cycles TP... | 18 Years - 60 Years | First People's Hospital of Foshan | |
| Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | NCT03503136 | Nasopharyngeal ... | docetaxel, neda... nedaplatin docetaxel, cisp... cisplatin docetaxel, cisp... docetaxel, neda... | 18 Years - 60 Years | Sun Yat-sen University | |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT | NCT05628922 | Nasopharyngeal ... | Toripalimab Induction chemo... | 18 Years - 70 Years | Fudan University | |
| Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma | NCT03427359 | Nasopharyngeal ... | cisplatin, cape... | 18 Years - 75 Years | The University of Hong Kong-Shenzhen Hospital | |
| Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | NCT01233843 | Squamous Cell H... | carboplatin 5 fluorouracil radiation thera... | 18 Years - 70 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
| Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT03815903 | Locally Advance... | Induction chemo... Chemoradiothera... | 18 Years - | Barretos Cancer Hospital | |
| A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects | NCT00943553 | Acute Myelogeno... | decitabine Indu... Induction Chemo... | 1 Year - 16 Years | Eisai Inc. | |
| Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00910117 | Head and Neck C... | nimotuzumab PF regimen (cis... | 18 Years - 70 Years | Fudan University | |
| Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT03020329 | Nasopharyngeal ... Children | Paclitaxel lipo... Cisplatin 5-fu Radical radioth... | - 18 Years | Sun Yat-sen University | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
